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The protective effect of farm animal exposure on childhood
allergy is modified by NPSR1 polymorphisms
Abstract
BACKGROUND: Little is known about the asthma candidate gene neuropeptide S receptor 1 (NPSR1)
in relation to environmental exposures, but recent evidences suggest its role as an effect modifier.
OBJECTIVES: To explore the interaction between NPSR1 polymorphisms and environmental
exposures related to farming lifestyle and to study the in vitro effects of lipopolysaccharide (LPS)
stimulation on NPSR1 expression levels. METHODS: We studied 3113 children from PARSIFAL, a
European cross-sectional study on environmental/lifestyle factors and childhood allergy, partly focused
on children brought up on a farm. Information on exposures and outcomes was primarily obtained from
parental questionnaires. Seven tagging polymorphisms were analysed in a conserved haplotype block of
NPSR1. Multivariate logistic regression was used to evaluate a multiplicative model of interaction.
NPSR1 protein and messenger RNA (mRNA) levels in monocytes were measured after LPS stimulation
by fluorescence activated cell sorting (FACS) and quantitative real-time polymerase chain reaction
(PCR). RESULTS: A strong interaction was seen between current regular contact to farm animals and
several NPSR1 polymorphisms, particularly rs323922 and rs324377 (p<0.005), with respect to allergic
symptoms. Considering the timing of initiation of such current regular farm animal contact, significant
interactions with these and two additional polymorphisms (SNP546333, rs740347) were revealed. In
response to LPS, NPSR1-A protein levels in monocytes were upregulated (p = 0.002), as were
NPSR1-A mRNA levels (p = 0.02). CONCLUSIONS: The effect of farm animal contact on the
development of allergic symptoms in children is modified by NPSR1 genetic background.
doi: 10.1136/jmg.2007.055137
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ABSTRACT
Background: Little is known about the asthma candidate
gene neuropeptide S receptor 1 (NPSR1) in relation to
environmental exposures, but recent evidences suggest
its role as an effect modifier.
Objectives: To explore the interaction between NPSR1
polymorphisms and environmental exposures related to
farming lifestyle and to study the in vitro effects of
lipopolysaccharide (LPS) stimulation on NPSR1 expression
levels.
Methods: We studied 3113 children from PARSIFAL, a
European cross-sectional study on environmental/lifestyle
factors and childhood allergy, partly focused on children
brought up on a farm. Information on exposures and
outcomes was primarily obtained from parental ques-
tionnaires. Seven tagging polymorphisms were analysed
in a conserved haplotype block of NPSR1. Multivariate
logistic regression was used to evaluate a multiplicative
model of interaction. NPSR1 protein and messenger RNA
(mRNA) levels in monocytes were measured after LPS
stimulation by fluorescence activated cell sorting (FACS)
and quantitative real-time polymerase chain reaction
(PCR).
Results: A strong interaction was seen between current
regular contact to farm animals and several NPSR1
polymorphisms, particularly rs323922 and rs324377
(p,0.005), with respect to allergic symptoms.
Considering the timing of initiation of such current regular
farm animal contact, significant interactions with these
and two additional polymorphisms (SNP546333,
rs740347) were revealed. In response to LPS, NPSR1-A
protein levels in monocytes were upregulated
(p = 0.002), as were NPSR1-A mRNA levels (p = 0.02).
Conclusions: The effect of farm animal contact on the
development of allergic symptoms in children is modified
by NPSR1 genetic background.
Epidemiological studies have shown that children
living on farms have a lower prevalence of IgE
mediated allergic diseases.1–5 The protective effects
have specifically been correlated to contact with
farm animals and farm milk consumption,5–10 with
exposure to endotoxins or moulds as possible
molecular explanations.7 11–13 The timing is impor-
tant, with prenatal and early life exposures
showing particularly strong protective effects.6 14
Interestingly, several innate immunity related
receptors, which directly interact with bacterial
components, have been reported to have hetero-
geneous genetic effects suggestive of gene–environ-
ment interactions.15–17
The neuropeptide S (NPS) receptor 1 (NPSR1;
earlier named GPR154 or GPRA) was positionally
cloned as an asthma candidate gene in families
from Finland and Canada, and has been replicated
for both childhood and adult populations of diverse
geographic origin.18–24 Neuropeptide S (NPS), the
ligand, shows overlapping expression patterns with
NPSR1 in several tissue types, including the
epithelium of human colon and bronchi.25 26
NPSR1 is further expressed by macrophages and
stimulation with NPS induces macrophage phago-
cytosis and chemotaxis.27 Stimulation of peripheral
blood mononuclear cells (PBMC) by lipopolysac-
charide (LPS), a potential molecular proxy for farm
animal exposure, has been shown to increase
mRNA levels of NPSR1.27 When the downstream
target genes of NPSR1 signalling were studied,
genes with ontology terms relating to immune
response and chemotaxis were found to be over-
represented.28 Interestingly, recent genetic studies
of NPSR1 have presented results suggesting gene–
environment interactions.23 24
PARSIFAL (Prevention of Allergy Risk factors for
Sensitisation In children related to Farming and
Anthroposophic Lifestyle) is a European cross-
sectional study designed to investigate the role of
different lifestyles and environmental exposures in
four groups: farm children, children from Steiner
schools (who often have an anthroposophic life-
style), and two corresponding reference groups.4
The large sample size and wealth of information
on environmental exposures makes this a unique
dataset for investigating gene–environment inter-
actions. We have previously demonstrated that
NPSR1 haplotypes are moderately associated with
asthma and atopic sensitisation in this sub-sample
of PARSIFAL.19 Here we explore potential effect
modification by NPSR1 on environmental expo-
sures related to the farming lifestyle. Since
protective effects of the farming environment have
been connected with endotoxins,7 12 13 we also
investigated the effects of LPS stimulation on
NPSR1 protein levels and mRNA expression levels
in monocytes.
METHODS
Study design
This work is based on a sub-sample of children
from the cross-sectional PARSIFAL study intended
for gene–environment analyses. Recruitment
and patient characteristics are described in detail
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elsewhere.4 In brief, the study included 14 893 children between
5–13 years old from four groups: farm children, Steiner school
children, and two appropriate reference groups (see below), in
five European countries (Austria, Germany, Holland, Sweden
and Switzerland). Ethical approval for the study, including
genetic analyses, was obtained in each country. The parents
completed a detailed questionnaire on their child’s allergic
diseases, infectious history and environmental exposures.4 6 29–31
The present analysis included 3113 children with complete
questionnaire data, adequate DNA material, and consent to
genetic analyses. Information on non-participation and compar-
ability between the whole PARSIFAL dataset and the genetic
sub-sample can be found elsewhere.4 19
Criteria for study group inclusion
Farm children included those children who currently were living
on a farm and whose parents were running the farm. Their
reference group was recruited from children in the same area but
who did not meet the inclusion criteria for farm children. The
Steiner group was recruited among children attending Steiner
schools, whose parents often have an anthroposophic lifestyle.
Their reference group was recruited from other schools in
similar suburban/rural areas. For further information see Alfve´n
et al.4
Health end point definitions and data on environmental
exposures
Information on environmental exposures and health end points
were reported by the parents of the children, except atopic
sensitisation (see below). Children who had ever been diagnosed
with asthma (by a physician), or with obstructive bronchitis
more than once, were classified as having asthma, while
children who reported sneezing, runny or stuffy nose in
combination with itchy eyes in the last 12 months without
having a cold at the same time were considered to have
rhinoconjunctivitis.4 Two common cut-off values for atopic
sensitisation were used: allergen-specific IgE level >0.35 kU/l
and >3.5 kU/l in either Phadiatop (a mix of common inhalant
allergens) and/or fx5 (a mix of common food allergens; Phadia
AB, Uppsala, Sweden) analyses. To increase the power of the
interaction analyses, the term ‘‘allergic symptoms’’ was broadly
defined as asthma and/or rhinoconjunctivitis based on the
definitions above. The health endpoint definitions used in this
study have been amply documented and used in several
PARSIFAL reports.4 9 10 14 19
Genotyping
Detailed information on the genotyping methodology, poly-
morphism selection and quality assessment is given elsewhere.19
In brief, seven tagging polymorphisms reported in the Laitinen
et al study18 were chosen in the conserved haplotype block of
NPSR1 and genotyped on a MALDI-TOF (matrix associated
laser desorption ionisation time of flight) platform. The selected
polymorphisms are rs323917, rs323922, rs324377, SNP546333,
rs324384, rs324396, and rs740347.
Analysis of NPSR1 protein expression after LPS stimulation
Peripheral blood from 10 healthy volunteers was drawn into
EDTA tubes and 200 ml was transferred to siliconised poly-
propylene FACS tubes, to minimise monocyte adherence. Blood
samples were mixed with 800 ml RPMI-1640 medium contain-
ing l-glutamine (0.29 mg/ml), penicillin (100 U/ml) and
streptomycin (100 mg/ml) (Gibco Lifetechnologies, Paisley,
UK) and incubated for 16 h at 37uC, with or without 10 ng/ml
LPS (Sigma-Aldrich, St Louis, Missouri, USA). For staining of
intracellular receptor epitopes, red blood cells were lysed and
leucocytes were fixed in 4% paraformaldehyde and permea-
bilised in 0.5% saponin. NPSR1-A and -B rabbit antibodies
and pre-immune serum negative controls were raised and
characterised as previously described18 26 27 and used with a
secondary PE labelled goat-anti-rabbit IgG antibody (Southern
Biotech, Alabama, USA). Samples were analysed on a
FACSCalibur flow cytometer with CellQuest software
(Becton Dickinson, San Jose, California, USA). Cell popula-
tions were detected using laser side and forward scatter and
the monocyte population was further confirmed using a
CD14-fluorescein isothiocyanate (FITC) antibody (Beckton
Dickinson). On average 2500 gated cells were analysed and
results are shown as median fluorescence intensity (MFI)
values with the pre-immune serum MFI subtracted. The
study was approved by the ethical review board at Karolinska
Institutet.
Analysis of NPSR1 mRNA expression after LPS stimulation
Human monocytes were obtained from 10 healthy blood donors
as previously described.27 Briefly, peripheral blood cells were
isolated by density gradient centrifugations using Ficoll-Paque
Plus (Amersham Biosciences, Uppsala, Sweden). PBMCs were
seeded onto cell culture bottles and incubated in complete RPMI
1640 medium supplemented with 0.29 mg/ml l-glutamine, 100
U/ml penicillin, 100 mg/ml streptomycin (Gibco
Lifetechnologies) and 10% fetal bovine serum (Sera-Lab,
Sussex, UK) for 10–20 min. Adherent monocytes were har-
vested by scraping, rested over night in complete RPMI medium
at a density of 1.56106 cells/ml, and cultured for 6 h and 24 h
with or without 10 ng/ml LPS (Sigma) at 37uC. Total RNA was
isolated with RNeasy Mini Kit (Qiagen, Hamburg, Germany)
from 3–96106 cells. cDNA was synthesised with TaqMan
reverse transcription reagents (Applied Biosystems, Foster City,
California, USA) and oligo dT primers. Quantitative real-time
polymerase chain reaction (PCR) was performed with ABI
PRISM 7500 Sequence Detection System applying SybrGreen
chemistry (Applied Biosystems). The primer sequences for
human NPSR1-A were 59-CCCCCTCATCTACTGTGT
CTTCA-39 (forward) and 59TCTCTCCCGGAACGTCA
TTCT-39 (reverse). The primer sequences for NPSR1-B and
elongation factor 1 a (EF-1a) have been documented pre-
viously.27 The relative gene expression differences were calcu-
lated with the comparative DDCT method using EF-1a as a
control.32 The study was approved by the ethical review board
at University of Helsinki.
Statistical analysis
Multivariate logistic regression was used for analyses and thus
departure from a multiplicative model of interaction on the
odds ratio (OR) scale was investigated. The statistical signifi-
cance of effect modification was tested by a likelihood ratio (LR)
test for the improvement of goodness of fit for the model when
including the interaction term. All confidence intervals were
calculated at the 95% level, p = 0.05.
The evaluated main determinants were focused on the
children’s lifetime or prenatal exposures, related to the farm
environment. Throughout the manuscript, ‘‘current’’ refers to
exposures that occurred during the last 12 months and
‘‘regular’’ refers to exposures that occurred at least once a
week. The investigated exposures were: ‘‘ever regular farm
Original article
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animal contact’’, ‘‘current regular farm animal contact’’,
‘‘current regular visits to stable or barn’’, ‘‘mother’s farm
animal contact during pregnancy’’, ‘‘mother worked regularly in
stable or barn during pregnancy’’, ‘‘ever consumption of farm
milk’’. For ‘‘current regular farm animal contact’’, timing of the
initiation of such regular exposure was further investigated
(current regular contact with initiation in first year of life/after
first year but more than a year ago/last 12 months), with no
current contact as the reference category. The seven genotyped
NPSR1 polymorphisms were evaluated as potential effect
modifiers. The polymorphisms were included as variables with
two genotype groups with reference ‘‘non-risk’’ genotype(s),
determined from a main effect logistic regression analysis of
each polymorphism separately (supplemental table 1). Two
polymorphisms (rs323917 and rs740347) had such low minor
allele frequencies that the rare minor allele homozygotes for
analytical reasons were pooled with the heterozygotes and a
dominant model was used. For the other five polymorphisms, a
recessive model was found to estimate the strongest main risk
effect.
The following potential confounding factors were evaluated:
country (Austria/Germany/Holland/Sweden/Switzerland), age
(5–6/7–8/9/10–11/12–13 years), sex (male/female), heredity
(mother’s or father’s reported asthma and/or rhinoconjunctivitis),
parental education (low/medium/high), maternal smoking during
pregnancy (yes/no), current smoking at home (yes/no), older
siblings (no/one/two/three or more older siblings), and study
group (farm/farm reference/Steiner school/Steiner reference).
Relevant confounders were identified starting from the full
model, with relevant confounding defined using the customary
criterion of approximately 10% change in the investigated effect
estimates. All analyses were carried out using the statistical
software STATA 9.0 (College Station, Texas, USA).
Where evidence for interaction was detected on the genotype
level, haplotype by environment analyses were performed in R
using the haplo.glm algorithm in the haplo.stats package,33
which includes an expectation maximisation (EM) step to
estimate probabilities for haplotypes. Evidence for an overall
haplotype–environment interaction was obtained through an
LR test for the improvement of goodness of fit for the model
when including versus excluding the interaction term.
The global significance for the interaction between NPSR1
and timing of current regular contact with farm animals in
determining risk of allergic symptoms was tested by permuta-
tion. The affection status was permuted 10 000 times, each
followed by seven multivariate logistic regressions as described
above, after which the number of nominally significant
interactions was recorded (randomised x2 tests). The proportion
of permutation tests where the number of nominally significant
LR tests exceeded or was equal to the original number of
significant tests provided the global p value.
Paired Wilcoxon signed rank tests were used to analyse the
effect of LPS stimulation on NPSR1 protein and mRNA levels.
RESULTS
Descriptive analyses and main effects
The prevalence of farm related exposures and allergic diseases in
the four study groups are presented in table 1. As expected, the
exposures were most common among farm children, but a
substantial proportion of children in the other groups was also
exposed. Of the investigated potential confounder variables,
only gender, heredity and study group were identified as
confounders of the investigated associations and interactions
and were thus included in all analyses described below. In an
initial analysis, protective main effects of the farm related
exposures on allergic symptoms and atopic sensitisation (most
pronounced for >3.5 kU/l) were observed in this sub-sample of
PARSIFAL (table 2). Overall genetic associations of NPSR1
haplotypes have previously been described in this population.19
In the gene–environment interaction analyses, our focus was on
the haplotype tagging polymorphisms for a number of reasons.
First, because of the ease of interpretation when using binary
genetic coding—that is, two levels of genetic exposure and two
levels of environmental exposures, which also increases the
Table 1 Prevalences of allergic phenotypes and farm related exposures among the PARSIFAL children, by
study group
Farm
children
n = 1307
Steiner
school
children
n = 686
Farm
reference
children
n = 654
Steiner
reference
children
n = 466
Allergic phenotypes (%)
Doctor’s diagnosis of asthma 6.2 7.0 11.6 12.9
Current symptoms of rhinoconjunctivitis 4.0 7.7 8.8 11.7
Allergic symptoms* 9.2 11.9 18.1 20.3
Atopic sensitisation (allergen specific IgE >0.35 kU/l) 22.7 29.0 34.5 37.8
Atopic sensitisation (allergen specific IgE >3.5 kU/l) 10.3 16.8 21.6 24.9
Farm related exposures (%)
Ever regular farm animal contact 92.7 45.2 36.2 20.9
Current regular farm animal contact 82.7 30.2 26.3 12.0
Current regular visits to stable or barn 81.9 23.3 17.2 7.4
Mother’s farm animal contact during pregnancy 79.9 18.7 15.5 6.6
Mother worked regularly in stable or barn during pregnancy 70.7 9.7 5.4 1.9
Ever consumption of farm milk 72.5 39.4 20.7 7.8
Current regular contact with farm animals, timing
No current regular farm animal contact 17.3 69.8 73.7 88.0
Current farm animal contact initiated during first year 53.2 10.3 8.5 1.9
Current farm animal contact initiated after first year but .12 months ago 15.8 9.1 5.9 1.3
Current farm animal contact initiated within last 12 months 13.7 10.8 12.0 8.8
PARSIFAL, Prevention of Allergy Risk factors for Sensitisation In children related to Farming and Anthroposophic Lifestyle.
*Doctor’s diagnosis of asthma and/or current symptoms of rhinoconjunctivitis.
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power of the analysis in that the cross-classification cell counts
increase. Second, choosing a baseline in the regression becomes
intuitive for single nucleotide polymorphisms (SNPs) where one
allele or genotypic combination defines risk in relation to
another, which is not true for haplotypes that are generally
numerous and show complex association patterns. Third, since
these polymorphisms were chosen as tags, they are actually
fewer than the total number of haplotypes observed, reducing
the risk of type I error. Minor allele frequencies and crude ORs
for the genotypic model selected for each polymorphism for use
in the interaction analyses are presented in supplemental table 1.
Interaction between farm animal exposure and NPSR1
polymorphisms
First, we assessed whether the protective effects of farm related
exposures was influenced by NPSR1 polymorphisms. Strong
effect modification for allergic symptoms was seen for regular
farm animal contact (table 3). The strongest effect modification
was seen for current regular farm animal contact, especially by
rs323922 and rs324377 (p value for interaction = 0.001 and
0.002). The protective effects of the other variables against
development of allergic symptoms were not dependent on
genotype (supplemental table 2). In a separate analysis for
asthma and rhinoconjunctivitis, rs324396 seemed to differ
somewhat between the phenotypes. However, the overall
trends were similar and the combined variable for allergic
symptoms was consistently showing more significant effects
(table 3). No gene–environment interactions were observed for
any of the main environmental determinants when atopic
sensitisation was used as outcome (neither >0.35 kU/l nor
>3.5 kU/l, data not shown).
When investigating the effect of timing of initiation of
current regular farm animal contact on allergic symptoms,
significant effect modification were seen with rs323922,
Table 2 Main environmental effects of farm related exposures on allergic symptoms and atopic sensitisation in all PARSIFAL children
Exposures
Number of exposed/
unexposed children
Outcome
Doctor’s diagnosis
of asthma
OR (95% CI){
Current symptoms of
rhinoconjunctivitis
OR (95% CI){
Allergic symptoms*
OR (95% CI){
Atopic sensitisation
(>3.5 kU/l)
OR (95% CI){
Ever regular farm animal contact 1852/1252 0.91 (0.66 to 1.26) 0.71 (0.50 to 1.01) 0.82 (0.63 to 1.07) 0.71 (0.55 to 0.91)
Current{ regular farm animal contact 1513/1591 0.80 (0.57 to 1.11) 0.70 (0.48 to 1.01) 0.78 (0.60 to 1.03) 0.74 (0.58 to 0.96)
Current regular visits to stable or barn 1369/1719 0.54 (0.37 to 0.79) 0.64 (0.42 to 0.97) 0.58 (0.43 to 0.79) 0.67 (0.51 to 0.89)
Mother’s farm animal contact during pregnancy 1280/1730 0.72 (0.48 to 1.05) 0.58 (0.38 to 0.89) 0.65 (0.48 to 0.89) 0.75 (0.56 to 0.96)
Mother worked regularly in stable or barn during pregnancy 1028/2065 0.51 (0.34 to 0.78) 0.56 (0.34 to 0.90) 0.54 (0.39 to 0.77) 0.62 (0.45 to 0.85)
Ever consumption of farm milk 1319/1581 0.50 (0.35 to 0.70) 0.66 (0.45 to 0.97) 0.56 (0.42 to 0.74) 0.95 (0.74 to 1.22)
PARSIFAL, Prevention of Allergy Risk factors for Sensitisation In children related to Farming and Anthroposophic Lifestyle.
*Doctor’s diagnosis of asthma and/or current symptoms of rhinoconjunctivitis.
{Odds ratios (OR) (with 95% confidence intervals (CI)) estimated from a logistic regression model, adjusting for gender, heredity and study group.
{ Current refers to exposures that have occurred during the last 12 months (for more detailed information see Methods).
Table 3 Effect modification of regular farm animal contact on allergic symptoms{ by NPSR1 genotypes, among all PARSIFAL children
SNPs with genotype
strata
Ever regular farm animal contact Current{ regular farm animal contact
Asthma
OR (95% CI)
Rhinoconjunctivitis
OR (95% CI)
Allergic symptoms
OR (95% CI)
Asthma
OR (95% CI)
Rhinoconjunctivis
OR (95% CI)
Allergic symptoms
OR (95% CI)
rs323917
CC (non-risk) 0.87 (0.62 to 1.22) 0.66 (0.46 to 0.97) 0.78 (0.59 to 1.03) 0.74 (0.52 to 1.04) 0.66 (0.44 to 0.98) 0.72 (0.54 to 0.96)
CG/GG 1.04 (0.47 to 2.33) 1.02 (0.45 to 2.28) 1.07 (0.56 to 2.03) 1.03 (0.46 to 2.28) 0.90 (0.39 to 2.05) 1.08 (0.57 to 2.07)
rs323922
GG/CG (non-risk) 1.08 (0.76 to 1.54) 0.78 (0.53 to 1.15) 0.98 (0.73 to 1.31)* 0.99 (0.68 to 1.42)* 0.82 (0.55 to 1.23)* 0.96 (0.71 to 1.30)**
CC 0.67 (0.36 to 1.25) 0.48 (0.24 to 0.98) 0.51 (0.30 to 0.87) 0.37 (0.18 to 0.75) 0.31 (0.14 to 0.71) 0.33 (0.18 to 0.60)
rs324377
AC/CC (non-risk) 1.08 (0.75 to 1.56) 0.81 (0.54 to 1.20) 1.00 (0.74 to 1.35)* 0.97 (0.67 to 1.41)* 0.80 (0.52 to 1.21) 0.95 (0.70 to 1.30)**
AA 0.70 (0.39 to 1.27) 0.48 (0.25 to 0.94) 0.53 (0.32 to 0.87) 0.43 (0.22 to 0.82) 0.36 (0.17 to 0.78) 0.38 (0.22 to 0.66)
SNP546333
AA/AG (non-risk) 0.37 (0.17 to 0.83)* 0.28 (0.10 to 0.78) 0.38 (0.20 to 0.75)* 0.52 (0.23 to 1.17) 0.22 (0.06 to 0.76) 0.46 (0.23 to 0.92)
GG 1.03 (0.73 to 1.44) 0.77 (0.53 to 1.11) 0.89 (0.67 to 1.18) 0.84 (0.59 to 1.18) 0.77 (0.52 to 1.14) 0.83 (0.62 to 1.10)
rs324384
CT/CC (non-risk) 1.01 (0.70 to 1.47) 0.74 (0.49 to 1.11) 0.93 (0.68 to 1.26) 0.91 (0.63 to 1.33) 0.76 (0.50 to 1.17) 0.90 (0.66 to 1.23)
TT 0.77 (0.47 to 1.25) 0.68 (0.39 to 1.16) 0.66 (0.44 to 1.00) 0.60 (0.36 to 1.00) 0.58 (0.32 to 1.04) 0.58 (0.38 to 0.90)
rs324396
CT/TT (non-risk) 1.18 (0.77 to 1.79) 0.62 (0.39 to 0.98) 0.97 (0.68 to 1.37) 0.96 (0.62 to 1.48) 0.64 (0.39 to 1.06) 0.90 (0.63 to 1.29)
CC 0.73 (0.48 to 1.10) 0.76 (0.48 to 1.21) 0.68 (0.48 to 0.97) 0.66 (0.43 to 1.00) 0.68 (0.42 to 1.10) 0.64 (0.45 to 0.92)
rs740347
GG (non-risk) 1.04 (0.73 to 1.49) 0.75 (0.50 to 1.11) 0.93 (0.69 to 1.25) 0.93 (0.64 to 1.34) 0.84 (0.56 to 1.27)* 0.92 (0.68 to 1.25)*
CC/CG 0.64 (0.37 to 1.11) 0.59 (0.32 to 1.09) 0.58 (0.36 to 0.92) 0.51 (0.29 to 0.92) 0.35 (0.17 to 0.73) 0.46 (0.28 to 0.77)
Odds ratios (OR) and 95% confidence intervals (CI) from a logistic regression model, adjusting for gender, heredity and study group.
{Doctor’s diagnosis of asthma and/or current symptoms of rhinoconjunctivitis.
{‘‘Current’’ refers to exposures that have occurred during the last 12 months.
*p value for interaction ,0.05 from a likelihood ratio (LR) test for the improvement of the regression model when including the interaction term.
**p value for interaction ,0.005 from an LR test for the improvement of the regression model when including the interaction term.
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rs324377, SNP546333, and rs740347 (tables 4 and for asthma
and rhinoconjunctivitis separately). If the current regular farm
animal contact was initiated during the first year of life, there
was a tendency towards a protective effect regardless of
genotype, while if the contact was initiated after early infancy,
the environmental effects differed substantially depending on
NPSR1 background (fig 1). To investigate further the consis-
tency of the interaction, a stratified analysis was performed for
farm children and for all non-farm children in the study (Steiner
school children combined with the two reference groups)
separately, and a similar interaction trend was observed in
both strata (table 4). The power was low for the separate
analyses of asthma and rhinoconjunctivitis, resulting in broader
confidence intervals and lack of cases for some combinations of
exposure and genotype (table 5).
To get a composite view of the interaction on the haplotype
level, the overall haplotype by environment interaction sig-
nificance was calculated for ever regular farm animal contact
(p = 0.06), current regular farm animal contact (p = 0.14), and
timing of initiation of current regular farm animal contact
(p = 0.01). Furthermore, the permuted p value for an overall
interaction between NPSR1 and timing of initiation of current
regular farm animal contact was 0.008 (10 000 permutations),
thus indicating a significant global gene–environment interac-
tion.
NPSR1 expression after LPS stimulation
Since the protective effects of the farming environment have
been attributed to high levels of endotoxins, for example, we
hypothesised that the observed interaction between farm
animal contact and NPSR1 might be linked to the innate
immune response. Therefore, the direct in vitro effects of LPS
stimulation on NPSR1 protein and mRNA levels were investi-
gated. CD14+ PBMCs from 10 blood donors showed a definite
pattern of upregulation of the NPSR1-A isoform after 16 h of
LPS stimulation (p = 0.002, supplemental fig 1 A, B and D), as
measured by FACS analysis, while we did not observe an
upregulation for the B isoform (supplemental fig 1 A, C, and E).
In the parallel mRNA investigations, where monocytes from 10
blood donors were stimulated with LPS, the NPSR1-A isoform
was found to show a modest upregulation trend at 6 h
(p = 0.02), while the B isoform response showed a similar but
Table 4 The effect of initiation of current regular farm animal contact on allergic symptoms* is modified by
NPSR1 genotypes, among all PARSIFAL children and in farmer and non-farmer subgroups
Exposure
Timing of initiation of current regular farm animal contact
Current farm
animal contact
initiated within last
12 months
Current farm
animal contact
initiated after
first year but
.12 months ago
Current farm
animal contact
initiated during
first year Overall interaction p value{
SNPs with
genotype strata OR (95% CI), all children
All
children
Non-farm
children{
Farm
children
rs323917 0.4018 0.4929 0.4880
CC 0.74 (0.50 to 1.12) 0.77 (0.48 to 1.24) 0.66 (0.45 to 0.96)
CG/GG 1.23 (0.49 to 3.12) 1.80 (0.69 to 4.71) 0.73 (0.31 to 1.75)
rs323922 0.0028 0.0599 0.0844
CG/GG 1.08 (0.72 to 1.61) 1.10 (0.69 to 1.76) 0.84 (0.57 to 1.23)
CC 0.19 (0.06 to 0.65) 0.37 (0.13 to 1.10) 0.39 (0.18 to 0.82)
rs324377 0.0033 0.0325 0.1570
AC/CC 1.12 (0.74 to 1.69) 1.10 (0.67 to 1.79) 0.79 (0.53 to 1.18)
AA 0.19 (0.06 to 0.62) 0.43 (0.16 to 1.14) 0.46 (0.23 to 0.90)
SNP546333 0.0288 0.1076 0.0305
AA/AG 0.22 (0.05 to 0.97) 0.17 (0.02 to 1.30) 0.74 (0.33 to 1.66)
GG 0.93 (0.63 to 1.37) 1.03 (0.66 to 1.60) 0.69 (0.48 to 1.00)
rs324384 0.2599 0.7049 0.5939
CT/CC 0.99 (0.64 to 1.51) 1.08 (0.66 to 1.78) 0.76 (0.51 to 1.15)
TT 0.53 (0.26 to 1.08) 0.59 (0.28 to 1.24) 0.58 (0.34 to 1.01)
rs324396 0.1245 0.4186 0.3298
CT/TT 1.10 (0.66 to 1.82) 1.20 (0.70 to 2.09) 0.67 (0.41 to 1.09)
CC 0.56 (0.33 to 0.96) 0.62 (0.33 to 1.16) 0.68 (0.44 to 1.06)
rs740347 0.0006 0.0278 0.0351
GG 1.11 (0.75 to 1.67) 1.20 (0.76 to 1.91) 0.72 (0.48 to 1.07)
CC/CG 0.22 (0.08 to 0.63) 0.26 (0.08 to 0.85) 0.70 (0.39 to 1.26)
PARSIFAL, Prevention of Allergy Risk factors for Sensitisation In children related to Farming and Anthroposophic Lifestyle; SNP,
single nucleotide polymorphism.
Odds ratios (OR) and 95% confidence intervals (CI) from a logistic regression model with all children, adjusting for gender, heredity
and study group. The reference groups (no current regular farm contact, stratified by genotype, total n = 1622) are not shown.
*Doctor’s diagnosis of asthma and/or current symptoms of rhinoconjunctivitis.
{Interaction as tested by the likelihood ratio (LR) test for the improvement of the model when including the interaction term.
{Steiner school children combined with the two reference groups of the PARSIFAL study.
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not significant trend (supplemental fig 1 F and G). The NPRS1
mRNA levels after 24 h of LPS stimulation showed a large
variation for both isoforms and no trends could be found (data
not shown).
DISCUSSION
In this study we show how effects of an environment can differ
depending on genetic background, with exposures to farm
animals exerting protective or risk effects for allergic symptoms,
depending on the inherited NPSR1 variant. Robust results on
interaction were also presented for a variable describing the
timing of initiation of current regular farm animal contact. It is
clear that independent replication is needed; however, the
temporal phenomenon observed here suggests that an environ-
mental exposure can show a more homogeneous effect if
introduced early in life, while different mechanisms may act
later on to modify such effects by, for example, a person’s
genetic setup. This was also supported by the finding that the
protective effect of farm animal contact during pregnancy was
not dependent on NPSR1 genotypes.
NPSR1 is expressed by macrophages,27 and thus has potential
for direct or indirect interaction with environmental endotoxins.
Table 5 The effect of initiation of current regular farm animal contact on asthma and rhinoconjunctivitis is modified by NPSR1 genotypes, among all
PARSIFAL children
Outcome
Exposure
Timing of initiation of current regular farm animal contact
Current farm animal
contact initiated within
last 12 months
Current farm animal contact
initiated after first year
but .12 months
Current farm animal contact
initiated during first year
Overall interaction
p value*
SNPs with genotype
strata OR (95% CI) OR (95% CI) OR (95% CI)
rs323917
Asthma CC (non-risk) 0.73 (0.46 to 1.19) 0.69 (0.38 to 1.24) 0.75 (0.48 to 1.16) 0.272
CG/GG 1.16 (0.36 to 3.73) 2.12 (0.70 to 6.46) 0.58 (0.18 to 1.85)
Rhinoconjunctivitis CC 0.77 (0.45 to 1.31) 0.75 (0.33 to 1.44) 0.51 (0.29 to 0.87) 0.915
CG/GG 1.10 (0.34 to 3.52) 1.10 (0.29 to 4.13) 0.62 (0.19 to 2.00)
rs323922
Asthma CG/GG (non-risk) 1.02 (0.62 to 1.68) 1.00 (0.66 to 1.80) 0.95 (0.61 to 1.51) 0.060
CC 0.34 (0.10 to 1.14) 0.44 (0.13 to 1.51) 0.36 (0.14 to 0.91)
Rhinoconjunctivitis CG/GG 1.06 (0.63 to 1.79) 0.97 (0.51 to 1.83) 0.60 (0.34 to 1.04) 0.038
CC 0.12 (0.02 to 0.90) 0.38 (0.09 to 1.66) 0.39 (0.14 to 1.08)
rs324377
Asthma AC/CC (non-risk) 1.07 (0.65 to 1.76) 0.95 (0.52 to 1.76) 0.91 (0.57 to 1.46) 0.095
AA 0.32 (0.10 to 1.08) 0.54 (0.18 to 1.59) 0.43 (0.19 to 0.99)
Rhinoconjunctivitis AC/CC 1.10 (0.64 to 1.88) 1.04 (0.54 to 2.01) 0.50 (0.27 to 0.92) 0.021
AA 0.12 (0.02 to 0.87) 0.34 (0.08 to 1.50) 0.50 (0.20 to 1.22)
SNP546333
Asthma AA/AG (non-risk) 0.18 (0.02 to 1.40) 5e-8 (3e-8 to 8e-8) 0.99 (0.41 to 2.38) 0.005
GG 0.93 (0.58 to 1.48) 1.01 (0.39 to 1.72) 0.73 (0.47 to 1.15)
Rhinoconjunctivitis AA/AG 0.21 (0.03 to 1.58) 0.35 (0.05 to 2.74) 0.16 (0.02 to 1.20) 0.160
GG 0.92 (0.56 to 1.52) 0.88 (0.48 to 1.63) 0.60 (0.36 to 1.00)
rs324384
Asthma CT/CC (non-risk) 0.99 (0.59 to 1.66) 0.93 (0.49 to 1.75) 0.86 (0.53 to 1.39) 0.471
TT 0.50 (0.21 to 1.22) 0.69 (0.30 to 1.61) 0.60 (0.31 to 1.14)
Rhinoconjunctivitis CT/CC 0.86 (0.48 to 1.54) 1.06 (0.55 to 2.05) 0.54 (0.29 to 0.98) 0.495
TT 0.71 (0.31 to 1.64) 0.40 (0.12 to 1.35) 0.54 (0.25 to 1.15)
rs324396
Asthma CT/TT (non-risk) 1.19 (0.65 to 2.16) 0.98 (0.48 to 2.01) 0.84 (0.48 to 1.47) 0.327
CC 0.53 (0.27 to 1.03) 0.71 (0.35 to 1.45) 0.70 (0.42 to 1.18)
Rhinoconjunctivitis CT/TT 0.72 (0.35 to 1.49) 1.18 (0.59 to 2.36) 0.34 (0.16 to 0.80) 0.128
CC 0.79 (0.41 to 1.53) 0.42 (0.15 to 1.21) 0.66 (0.36 to 1.23)
rs740347
Asthma GG (non-risk) 1.07 (0.66 to 1.75) 1.27 (0.74 to 2.19) 0.75 (0.47 to 1.21) NA{
CC/CG 0.27 (0.08 to 0.90) NA* 0.90 (0.47 to 1.72)
Rhinoconjunctivitis GG 1.11 (0.66 to 1.87) 0.93 (0.48 to 1.81) 0.61 (0.34 to 1.07) 0.063
CC/CG 0.21 (0.05 to 0.88) 0.53 (0.16 to 1.79) 0.34 (0.13 to 0.93)
PARSIFAL, Prevention of Allergy Risk factors for Sensitisation In children related to Farming and Anthroposophic Lifestyle.
Odds ratios (OR) and 95% confidence intervals (CI) from a logistic regression model, adjusting for gender, heredity and study group.
*Interaction as tested by the likelihood ratio (LR) test for the improvement of the model when including the interaction term.
{NA means that cases are missing for this combination, thus no OR or overall interaction p value can be calculated.
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Since the protective effects of farm animal exposure have been
connected with higher levels of endotoxins, for example, we
investigated the in vitro effects of LPS and found that the NPSR1-
A (but not B) protein levels were specifically upregulated by LPS in
CD14+ PBMCs (monocytes). We further demonstrated that
purified monocytes upregulate NPSR1-A (with a similar trend
for NPSR1-B) mRNA levels after 6 h of LPS stimulation.
Previously, the more heterogeneous cell population PBMCs have
been shown to upregulate NPSR1 mRNA levels after 16 h of LPS
stimulation for both isoforms.27
A limitation of this experiment is its small sample size,
although it is larger than the previous study.27 It should also be
noticed that several other environmental components typical
for farm animal exposure might affect NPSR1 abundance in
monocytes and macrophages, and would be worthy of study.34–36
Further, the most relevant tissue or cell type for a functional
study is not entirely clear. Here we focused on peripheral
blood monocytes, since NPSR1 has been demonstrated to
affect their function27 and because innate immunity in general
has been of interest in previous studies with similar scope.14 15
Although more thorough studies are needed, all experimental
results taken together suggest that NPSR1 levels are affected
by LPS stimulation, and this can serve as a first molecular
hypothesis for our epidemiological results.
The NPSR1 polymorphisms that were investigated in this
study are located in the second intron of the gene, comprising a
block of tight linkage disequilibrium that was originally
identified as associated to asthma related traits.18 So far, no
functional characteristics have been described for these poly-
morphisms, while many hypotheses can be proposed, including
transcription factor binding, regulation of alternative splicing of
the two isoforms A and B, and their potential linkage
disequilibrium to a disease causing polymorphism. The hetero-
genic responses to LPS stimulation observed here may suggest
that inherited NPSR1 variants have an effect. Our limited
sample size makes this difficult to assess, but further subject
and data collections are ongoing to address this important issue.
The large sample size of the PARSIFAL study and its wealth
of information on environmental exposures make it suitable for
assessment of gene–environment interactions. The subset of the
study available for genetic analyses has earlier been concluded
essentially representative.19 Further, we have previously noted
that the frequencies of genetic variants across the countries
were quite homogeneous, suggesting that population stratifica-
tion is not expected.19 In the present analyses we investigated
typical farm related environmental exposure in all the four
study groups. The finding that timing of initiation of farm
animal contact is important when studying NPSR1 modifica-
tion was further analysed in farmer and non-farmer children,
separately. It should be noted that when analysing only
farmers, there are few individuals in the reference group (no
current exposure), while there are fewer exposed for the non-
farmers. Nevertheless, it is reassuring that both analyses present
a similar interaction, despite the different general environments
of the groups of children.
When effect modification between NPSR1 and farm related
variables was analysed, we used both atopic sensitisation and
allergic symptoms as outcome. However, it was only for allergic
symptoms that we found evidence for effect modification. This
could be due to chance, but of note is that some studies have
suggested that different environmental exposures related to the
farming lifestyle are responsible for protection against different
types of allergic phenotypes.6 14 The definition of sensitisation
by serology measurements may also be of importance. For
completeness, we performed all analyses using two common
cut-offs, >0.35 kU/l and >3.5 kU/l, but no genetic interaction
effects were seen with either cut-off. We have also performed
interaction analyses by stratifying for sensitisation (that is,
allergic symptoms with or without detectable sensitisation) and
there were trends for interaction in both groups, emphasising
the independence of these two phenotypes (data not shown).
For allergic symptoms, we performed interaction analyses for
asthma and rhinoconjunctivitis separately and also for a
combined variable of the two. The incentive for the combina-
tion was to increase the number of cases, thus acquiring a higher
statistical power to perform detailed gene–environment inter-
action analysis. Some of the observed small differences between
the symptoms might be of biological interest, but we have to
conclude that a larger, better powered study would be needed to
make any such conclusions.
We have recently used this population to evaluate the overall
association between NPSR1 variants and childhood allergic
disease.19 Here, we chose to consider how environmental effects
could be modified by an inherited NPSR1 allele. This seemed
intuitive, because the genetic setup is fixed at birth, while the
Figure 1 The effect of current regular farm animal contact on allergic
symptoms is dependent on NPSR1 polymorphism in the PARSIFAL
(Prevention of Allergy Risk factors for Sensitisation In children related to
Farming and Anthroposophic Lifestyle) children. Odds ratios (OR) and
95% confidence intervals (CI) for the effect of timing of current regular
farm animal contact in strata of rs324377 are shown. The two reference
groups (no current regular exposure to farm animals, stratified by
genotype), are indicated at OR = 1. The following group includes those
with current regular farm exposure that was initiated during the first year
of life, the next group after the first year until recently, and the last group
initiated their current regular farm animal contact recently (last
12 months). All groups are compared to the reference group (that has no
current farm animal contact) in their genotype stratum.
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environment is interchangeable. However, statistically the
interaction effects could be viewed in both ways and the
presented results implicitly mean that the genetic effects also
differ depending on environment. Of interest is that the tag
polymorphisms that showed association in our first study
(rs324384, rs324396, distinguishing H1/H3 from rest) did not
show significant interaction in this study. Further, when
performing haplotype–environment analyses, the haplotypes
showing effect modification (using H1 as reference) were H2
and H4, both of which did not show association in our previous
analysis with the PARSIFAL children,19 but were associated with
risk in the original NPSR1 identification study.18 These new
findings emphasise the importance of considering gene–envir-
onment effects in association studies of complex diseases such
as asthma and atopic sensitisation. Of note, a recent association
study of NPSR1 presented flip-flop association patterns for
different populations, possibly suggesting that different envir-
onments might cause the discrepant association patterns.24
Consideration of environmental exposures and simultaneously
the timing of exposures may be more important than earlier
perceived.
In conclusion, this study adds NPSR1 to the list of genes
suggested to modify the protective effects of environmental
exposures,15–17 and further indicates that genetic effect modifica-
tion of environmental exposures may be influenced by the
timing of initiation of such exposures.
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